The Discounted Cash Flow (DCF) valuation of Duopharma Biotech Bhd (DPHARMA.KL) is 1.14 MYR. With the latest stock price at 1.29 MYR, the upside of Duopharma Biotech Bhd based on DCF is -11.3%.
Based on the latest price of 1.29 MYR and our DCF valuation, Duopharma Biotech Bhd (DPHARMA.KL) is a sell. selling DPHARMA.KL stocks now will result in a potential gain of 11.3%.
| Range | Selected | |
| WACC / Discount Rate | 8.7% - 11.2% | 10.0% |
| Long-term Growth Rate | 2.0% - 4.0% | 3.0% |
| Fair Price | 0.82 - 1.78 | 1.14 |
| Upside | -36.5% - 37.6% | -11.3% |